Expert Guidance on the Expanding Role of Immunotherapy in HNSCC

Download All
Download these HNSCC slides, Webcast, and resource guide for expert perspectives on the optimal use of immunotherapy and communication strategies for patients with head and neck cancer.
Barbara Burtness, MD
Program Director
Cristina P. Rodriguez, MD
Program Director

On-Demand Webcast

Get expert insights on the use of immune checkpoint inhibitors for the treatment of patients with recurrent HNSCC in this on-demand Webcast of a CCO live meeting.

Barbara Burtness, MD
Program Director
Cristina P. Rodriguez, MD
Program Director
Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: April 23, 2020 Expired: No longer available for credit
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings